Debleena Dey

Title: Debleena Dey: Innovator in Anti-Diabetic Research

Introduction

Debleena Dey is a prominent inventor based in Kolkata, India. She has made significant contributions to the field of diabetes research, particularly in developing innovative methods for treating type II diabetes. Her work focuses on utilizing herbal extracts to enhance insulin signaling pathways.

Latest Patents

Debleena Dey holds a patent for her invention titled "Herbal extract and compound lupinoside and its analogues as anti-diabetic type II drugs from plant Pueraria tuberosa." This invention relates to a method of preventing and treating type 2 diabetes. It also involves augmenting Glut4 phosphorylation and Glut4 translocation to target cell membranes, thereby enhancing insulin signaling in the transduction pathway. The process she developed is simplified and cost-effective, allowing for the extraction of active compounds, particularly the n-butanol fraction and the active molecule Lupinoside PA (LPA), which are useful in managing diabetes type 2. She has 1 patent to her name.

Career Highlights

Debleena Dey is associated with the Council of Scientific and Industrial Research, where she continues her research and development efforts. Her work has garnered attention for its potential impact on diabetes treatment, showcasing her dedication to scientific advancement.

Collaborations

Debleena has collaborated with notable colleagues, including Swapan Kumar Mandal and Mohua Mukherjee, who have contributed to her research endeavors.

Conclusion

Debleena Dey's innovative work in the field of anti-diabetic research highlights her commitment to improving health outcomes through scientific discovery. Her contributions are paving the way for new treatments in diabetes management.